Published in J Drug Target on September 01, 2002
Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery. AAPS PharmSciTech (2009) 1.08
Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci (2009) 1.07
Modeling kinetics of subcellular disposition of chemicals. Chem Rev (2009) 0.96
Solid Lipid Nanoparticles as Efficient Drug and Gene Delivery Systems: Recent Breakthroughs. Adv Pharm Bull (2015) 0.82
Advances in biomimetic regeneration of elastic matrix structures. Drug Deliv Transl Res (2012) 0.78
Nanotechnology in dermatology. An Bras Dermatol (2014) 0.75
Enhancement of transdermal penetration and bioavailability of poorly soluble acyclovir using solid lipid nanoparticles incorporated in gel cream. Indian J Pharm Sci (2013) 0.75
Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A (1992) 8.59
Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem (1992) 4.33
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. Eur J Pharm Biopharm (1998) 2.44
Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol (1999) 1.96
Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol (1997) 1.78
Leukemia following chemotherapy for ovarian cancer. N Engl J Med (1990) 1.76
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol (1998) 1.70
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm (2000) 1.58
The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol (2006) 1.55
Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol (2001) 1.48
Occlusive paromomycin for cutaneous leishmaniasis. Lancet (1997) 1.43
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
[Axillary hyperhidrosis: successful treatment with botulinum toxin A]. Hautarzt (1998) 1.39
[Pyoderma]. Hautarzt (1998) 1.37
Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Personality and socialization correlates of vicarious emotional responding. J Pers Soc Psychol (1991) 1.29
Influence of serum protein binding on the in vitro activity of anti-fungal agents. Infection (1996) 1.23
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm (2006) 1.22
Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release (2000) 1.21
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol (2004) 1.19
Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell Microbiol (2000) 1.19
Late cutaneous schistosomiasis representing an isolated skin manifestation of schistosoma mansoni infection. Dermatology (2000) 1.19
[Normal pH value of human skin]. Hautarzt (1986) 1.16
Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res (1997) 1.16
The relations of parental characteristics and practices to children's vicarious emotional responding. Child Dev (1991) 1.16
Empathy-based helping: is it selflessly or selfishly motivated? J Pers Soc Psychol (1987) 1.16
Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun (1993) 1.14
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study. Antimicrob Agents Chemother (1991) 1.13
An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.11
The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology (2001) 1.09
Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target (1996) 1.09
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol (1995) 1.07
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol (2000) 1.07
Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsul (1999) 1.06
Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother (1999) 1.05
Characterisation of penicillinase producing gonococci isolated in Munich, 1981-6. Genitourin Med (1988) 1.02
The role of sympathy and altruistic personality traits in helping: a reexamination. J Pers (1989) 1.02
1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol (2001) 0.99
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. Hautarzt (1989) 0.99
Epithelial cells and innate antifungal defense. J Dent Res (2010) 0.99
Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect (2013) 0.99
Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers. Antimicrob Agents Chemother (1987) 0.99
High-performance liquid chromatography analysis of porphyrins in Propionibacterium acnes. Arch Dermatol Res (2000) 0.98
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob Agents Chemother (1993) 0.98
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration. J Am Acad Dermatol (1990) 0.98
The role of vitamin E in normal and damaged skin. J Mol Med (Berl) (1995) 0.97
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm (2007) 0.97
The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med (Berl) (1996) 0.96
Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin Exp Rheumatol (2002) 0.96
Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J (2000) 0.96
Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests. Chemotherapy (1998) 0.96
Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. Arch Dermatol (1992) 0.95
Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci (2007) 0.95
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts. Int J Antimicrob Agents (2001) 0.95
Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro (2005) 0.95
Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol (1986) 0.95
Dorfman-Chanarin syndrome in a Turkish kindred: conductor diagnosis requires analysis of multiple eosinophils. Acta Derm Venereol (2000) 0.95
Atenolol interaction with aspirin, allopurinol, and ampicillin. Clin Pharmacol Ther (1983) 0.94
The KEX2 gene of Candida glabrata is required for cell surface integrity. Mol Microbiol (2001) 0.94
Onychomycosis. Mycoses (2007) 0.94
The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation. Infect Immun (2010) 0.94
Aquarium dermatitis: cercarial dermatitis in an aquarist. Dermatology (1998) 0.93
Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects. Skin Pharmacol Physiol (2004) 0.92
Bacteriophages induced by ciprofloxacin in a Borrelia burgdorferi skin isolate. Zentralbl Bakteriol (1993) 0.92
Plasmid content and protein I serovar of non-penicillinase-producing gonococci isolated in Munich. Epidemiol Infect (1988) 0.92
Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J Microencapsul (2006) 0.91
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol (1999) 0.91
The use of systemic antimycotics in dermatotherapy. Eur J Dermatol (2000) 0.91
Interaction kinetics of tetramethylrhodamine transferrin with human transferrin receptor studied by fluorescence correlation spectroscopy. Biochemistry (1999) 0.90
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release (2005) 0.90
Acid nuclear extracts as mediators of gene transfer and expression. Biochim Biophys Acta (1998) 0.90
Preputial abscesses caused by beta-lactamase-producing gonococci. Cutis (1985) 0.90
Atomic force microscopy studies of solid lipid nanoparticles. Pharm Res (1996) 0.90
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol (2006) 0.89
Cowpox virus infection in an 11-year-old girl. J Am Acad Dermatol (2000) 0.89
UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.89
Liposomes: a drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst (1994) 0.89
[The correlation between biotype and antifungal sensitivity of Candida albicans]. Mykosen (1987) 0.89
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie (2005) 0.88
Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm (2000) 0.88
Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol (1999) 0.88